Myelodysplastic Syndrome Versus Idiopathic Cytopenia of Undetermined Significance: the Role of Morphology in Distinguishing Between These Entities
Overview
Overview
Journal
Rev Bras Hematol Hemoter
Publisher
Elsevier
Specialty
Hematology
Date
2014 Jan 31
PMID
24478612
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Ribeiro L, de Paula E Rev Bras Hematol Hemoter. 2016; 38(4):279-280.
PMID: 27863751 PMC: 5119659. DOI: 10.1016/j.bjhh.2016.08.003.
References
1.
Valent P, Horny H, Bennett J, Fonatsch C, Germing U, Greenberg P
. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res. 2007; 31(6):727-36.
DOI: 10.1016/j.leukres.2006.11.009.
View
2.
Schroeder T, Ruf L, Bernhardt A, Hildebrandt B, Aivado M, Aul C
. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients. Ann Oncol. 2010; 21(11):2267-2271.
DOI: 10.1093/annonc/mdq233.
View
3.
Valent P, Bain B, Bennett J, Wimazal F, Sperr W, Mufti G
. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res. 2011; 36(1):1-5.
DOI: 10.1016/j.leukres.2011.08.016.
View